Online first
Current issue
Archive
Special Issues
About the Journal
Publication Ethics
1/2021 vol. 28
Stats
CC BY-NC 3.0 Poland
Get citation
RESEARCH PAPER
Modification of exhaled air nitric oxide in patients with asthma – cortisone monotherapy or dual inhalation therapy?
Victoria Maria Ruta 1
,
 
Nicoleta Stefania Motoc 2
,
 
Doina Adina Todea 2
,
 
Teodora Gabriela Alexescu 3
,
 
Dan Valean 4
,
 
Stefania Cozac 4
,
 
Sorina Cezara Coste 3
,
 
Razvan Andrei Codea 5
,
 
Rodica Ana Ungur 6
,
 
Carmen Monica Pop 2
,
 
Adina Man Milena 2
 
 
 
More details
Hide details
1
Iuliu Hatieganu’ University of Medicine and Pharmacy, Cluj-Napoca, Romania
 
2
Department of Pneumology, ’Iuliu Hatieganu’ University of Medicine and Pharmacy, Cluj-Napoca, Romania
 
3
Department of Internal Medicine, ‚Iuliu Hatieganu’ University of Medicine and Pharmacy, Cluj-Napoca, Romania
 
4
MD student ‚Iuliu Hatieganu’ University of Medicine and Pharmacy, Cluj-Napoca, Romania
 
5
Faculty of Veterinary Medicine, University of Agricultural Science and Veterinary Medicine, Cluj-Napoca, Romania
 
6
Department of Rehabilitation, ‘Iuliu Hatieganu’ University of Medicine and Pharmacy Cluj-Napoca, Cluj-Napoca, Romania
 
 
Corresponding author
Rodica Ana Ungur   

, Department of Rehabilitation, ‚Iuliu Hatieganu’ University of Medicine and Pharmacy Cluj-Napoca, 46-50 Viilor Street, 400347, Cluj-Napoca, Romania.
 
 
Ann Agric Environ Med. 2021;28(1):89-93
DOI: https://doi.org/10.26444/aaem/130712
 
 
Article (PDF)
References (40)
 
KEYWORDS
asthma
dual therapy
fractional expired nitric oxide (FeNO)
inhalation monotherapy
wheezing
 
TOPICS
Health effects of chemical pollutants in agricultural areas , including occupational and non-occupational effects of agricultural chemicals (pesticides, fertilizers) and effects of industrial disposal (heavy metals, sulphur, etc.) contaminating the atmosphere, soil and water
 
ABSTRACT
Introduction:
Asthma, a chronic lung disease, is a major health challenge worldwide with increased addressability to health services. There are different asthma phenotypes, which have different evolution and can be specifically tracked. The measurement of fractional expired nitric oxide (FeNo) with different devices reflects the eosinophilic inflammation of the airways, and can be used to evaluate the allergic phenotype and predict the treatment responses. The new GINA (Global Initiative for Asthma) guideline recommends FeNO monitoring to assess adherence to cortisone treatment in high doses before prescribing biological treatment, and as a means of monitoring the decrease in oral corticosteroid treatment.

Objective:
The aim of the study is to analyze the applicability of FeNO in monitoring response to therapy.

Material and methods:
An observational study was carried out on 129 subjects with a previously established diagnosis of asthma. The research was based on the determination of FeNO with NObreath. Those with intermediate FeNO received a low dose of inhaled corticosteroids in mono/dual therapy, those with increased FeNO received medium ICS mono/dual therapy. FeNO testing, its values and doses of ICS were below the the ATS / ERS guidelines.

Results:
FeNO reduction is strictly dependent on the cortisone dose. Applying the dual therapy from the beginning does not bring additional benefits in comparison with cortisone in monotherapy, in terms of FeNO value.

Conclusions:
Recommendations that include FeNO testing can help monitor response to treatment.

ACKNOWLEDGEMENTS
The first two authors have equal rights to this paper.
Ruta VM, Motoc NS, Todea DA, Alexescu TG, Valean D, Cozac S, Coste SC, Codea RA, Ungur RA, Pop CM, Milena AM. Modification of exhaled air nitric oxide in patients with asthma: cortisone monotherapy or dual inhalation therapy? Ann Agric Environ Med.doi: 10.26444/aaem/130712
 
REFERENCES (40)
1.
Global Strategy for Asthma Management and Prevention (2018 update) https://ginasthma.org/wp-conte... (access:2020.09.08).
Google Scholar
 
 
2.
Masefield S, Edwards J, Hansen K, Hamerlijnck D, Lisspers K, Schee M van der, et al. The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP). Eur Respir J. 2017; 49(5).
Google Scholar
 
 
3.
Croitoru A, Bogdan MA. [Evidences related to pulmonary rehabilitation in the respiratory pathology]. Pneumol Buchar Rom. 2014 Jun; 63(2): 88–90, 92–5.
Google Scholar
 
 
4.
Nistor AR, Onac I, Stefanescu A, Borda IM, Ciortea V, Ungur R. EBSCOhost | 108800415 | The role of singing therapy in pulmonary rehabilitation. Palestrica of the Third Millennium Civilization & Sport. 2015; 16(2).
Google Scholar
 
 
5.
Georas SN, van Wijngaarden E, Rich DQ. Air pollution and asthma incidence: doubt no more? Lancet Respir Med. 2015 Dec; 3(12): 902–3.
Google Scholar
 
 
6.
Rezaei Vandchali N, Koolivand A, Ranjbar A, et al. Oxidative toxic stress and p53 level in healthy subjects occupationally exposed to outdoor air Pollution – a cross-sectional study in Iran. Ann Agric Environ Med. 2020. doi: 10.26444/aaem/126313.
CrossRef
 
Google Scholar
 
 
7.
Ungur R, Dronca M, Crăciun EC, Rusu RL, Văleanu M, Onac I, et al. Improvement of total antioxidant status, a possible bioeffect of the ultrasound therapy – a pilot study. Rev Romana Med Lab. 2011; 19(2): 177–83.
Google Scholar
 
 
8.
Pignatelli P, Menichelli D, Pastori D, Violi F. Oxidative stress and cardiovascular disease: new insights. Kardiol Pol. 2018; 76(4): 713–22.
Google Scholar
 
 
9.
Cozma A, Sitar-Taut A, Orăşan O, Leucuta D, Alexescu T, Stan A, et al. Determining Factors of Arterial Stiffness in Subjects with Metabolic Syndrome. Metab Syndr Relat Disord. 2018 Sep 5; 16(9): 490–6.
Google Scholar
 
 
10.
Barnes PJ, Liew FY. Nitric oxide and asthmatic inflammation. Immunol Today. 1995 Mar; 16(3): 128–30.
Google Scholar
 
 
11.
Lemière C, Ernst P, Olivenstein R, Yamauchi Y, Govindaraju K, Ludwig MS, et al. Airway inflammation assessed by invasive and noninvasive means in severe asthma: Eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol. 2006 Nov 1; 118(5): 1033–9.
Google Scholar
 
 
12.
Matacuta I, Neamtu MB, Bodrug N, Dobrota L, Neamtu ML, Caprita H. Metode de explorare funcţională pulmonară. Rev Stiintifico-Pract Info-Med. 2013; 1(21): 32–6.
Google Scholar
 
 
13.
Hoyte FCL, Gross LM, Katial RK. Exhaled Nitric Oxide: An Update. Immunol Allergy Clin North Am. 2018; 38(4): 573–85.
Google Scholar
 
 
14.
Pocket guide for asthma management and prevention (GINA-2019) https://ginasthma.org/wp-conte... (access:2020.09.08).
Google Scholar
 
 
15.
Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications. Am J Respir Crit Care Med. 2011 Sep 1; 184(5): 602–15.
Google Scholar
 
 
16.
Terada A, Fujisawa T, Togashi K, Miyazaki T, Katsumata H, Atsuta J, et al. Exhaled Nitric Oxide Decreases during Exercise-induced Bronchoconstriction in Children with Asthma. Am J Respir Crit Care Med. 2001 Nov 15; 164(10): 1879–84.
Google Scholar
 
 
17.
NObreath manual https://www.nobreathfeno.com/w... (access: 2020.09.08).
Google Scholar
 
 
18.
Malinovschi A, Backer V, Harving H, Porsbjerg C. The value of exhaled nitric oxide to identify asthma in smoking patients with asthma-like symptoms. Respir Med. 2012 Jun 1; 106(6): 794–801.
Google Scholar
 
 
19.
Bjermer L, Alving K, Diamant Z, Magnussen H, Pavord I, Piacentini G, et al. Current evidence and future research needs for FeNO measurement in respiratory diseases. Respir Med. 2014 Jun 1; 108(6): 830–41.
Google Scholar
 
 
20.
Trofor A, Petris O, Trofor L, Man MA, Filipeanu D, Miron R. Biochemistry in Assessing Tobacco Exposure – Smokers versus Non-smokers Correlations with clinical practice. Rev Chim. 2017 Jun 15; 68(5): 1002–6.
Google Scholar
 
 
21.
Trofor AC, Man MA, Marginean C, Dumitru F, Trofor L. Smoking cessation for free: outcomes of a study of three Romanian clinics. Open Med. 2016 Dec 30; 11(1): 605–10.
Google Scholar
 
 
22.
Man MA, Man SC, Motoc NŞ, Pop CM, Trofor AC. Fatal hypersensitivity pneumonitis after chemical occupational exposure. Romanian J Morphol Embryol Rev Roum Morphol Embryol. 2017; 58(2): 627–34.
Google Scholar
 
 
23.
Sastre J, Costa C, del Garcia Potro M, Aguado E, Mahillo I, Fernández-Nieto M. Changes in exhaled nitric oxide after inhalation challenge with occupational agents. J Investig Allergol Clin Immunol. 2013; 2 3 (6): 4 21–7.
Google Scholar
 
 
24.
Rhee H, Love T, Mammen J. Comparing Asthma Control Questionnaire (ACQ) and National Asthma Education and Prevention Program (NAEPP) asthma control criteria. Ann Allergy Asthma Immunol. 2019 Jan 1; 122(1): 58–64.
Google Scholar
 
 
25.
Global Initiative for asthma https://ginasthma.org/wp-conte... (access: 2020.09.08).
Google Scholar
 
 
26.
Shim JY. Association of wheezing phenotypes with fractional exhaled nitric oxide in children. Korean J Pediatr. 2014 May; 57(5): 211–6.
Google Scholar
 
 
27.
LaForce C, Brooks E, Herje N, Dorinsky P, Rickard K. Impact of exhaled nitric oxide measurements on treatment decisions in an asthma specialty clinic. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2014 Dec; 113(6): 619–23.
Google Scholar
 
 
28.
Tudorache E, Fildan AP, Frandes M, Dantes E, Tofolean DE. Aging and extrapulmonary effects of chronic obstructive pulmonary disease. Clin Interv Aging. 2017 Aug 16; 12: 1281–7.
Google Scholar
 
 
29.
Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald JM, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008; 31(1): 143–78.
Google Scholar
 
 
30.
Hauber H-P, Gotfried M, Newman K, Danda R, Servi RJ, Christodoulopoulos P, et al. Effect of HFA-flunisolide on peripheral lung inflammation in asthma. J Allergy Clin Immunol. 2003 Jul; 112(1): 58–63.
Google Scholar
 
 
31.
Hossny E, Rosario N, Lee BW, Singh M, El-Ghoneimy D, SOH JY, et al. The use of inhaled corticosteroids in pediatric asthma: update. World Allergy Organ J https://www.ncbi.nlm.nih.gov/p... (access: 2020.09.08).
Google Scholar
 
 
32.
Wang Z, Pianosi P, Keogh K, Zaiem F, Alsawas M, Alahdab F, et al. The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management. Agency for Healthcare Research and Quality; https://effectivehealthcare.ah... (access: 2020.09.08).
Google Scholar
 
 
33.
Zetterström O, Buhl R, Mellem H, Perpiñá M, Hedman J, O’Neill S, et al. Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J. 2001 Aug 1; 18(2): 262–8.
Google Scholar
 
 
34.
Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. The Lancet. 1994 Jul 23; 344(8917): 219–24.
Google Scholar
 
 
35.
Fingleton J, Hardy J, Baggott C, Pilcher J, Corin A, Hancox RJ, et al. Description of the protocol for the PRACTICAL study: a randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma. BMJ Open Respir Res https://www.ncbi.nlm.nih.gov/p... (access:2020.09.08).
Google Scholar
 
 
36.
Budin CE, Maierean AD, Ianosi ES, Socaci A, Buzoianu AD, Alexescu TG, et al. Nocturnal Hypoxemia, a Key Parameter in Overlap Syndrome. Rev Chim. 2019 Mar 15; 70(2): 449–54.
Google Scholar
 
 
37.
Liu L, Urban P, Hunt JF, Wilkinson P, Laning K, Gaston B. Changes in Exhaled Nitric Oxide and Breath pH during Fluticasone Wean in Asthma. Respiration. 2010; 79(3): 193–9.
Google Scholar
 
 
38.
Malinovschi A, Van Muylem A, Michiels S, Michils A. FeNO as a predictor of asthma control improvement after starting inhaled steroid treatment. Nitric Oxide. 2014; 40: 110–6.
Google Scholar
 
 
39.
Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic Inflammation in Severe Persistent Asthma. Am J Respir Crit Care Med. 1999 Nov 1; 160(5): 1532–9.
Google Scholar
 
 
40.
Sl J, P H, Jo C, Em F, Rj H, Cr M, et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J. 2002 Sep 1; 20(3): 601–8.
Google Scholar
 
 
Share
Send by email
RELATED ARTICLE
Relationship between concentration of air pollutants and frequency of hospitalisations due to respiratory diseases
Role of vitamin D3 in selected pulmonary diseases with particular emphasis on lung fibrosis
Importance of food allergy and food intolerance in allergic multimorbidity
Influence of environment on residence and selected demographic and clinical parameters of preschool children with IgE-dependent asthma
Occupational health problems associated with increased recycling of household waste
Indexes
 
Keywords index
Topics index
Authors index
eISSN:1898-2263
ISSN:1232-1966
Journals System - logo
Improvement of editorial platform - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher Education allocated to the activities of disseminating science.

Improvement of visual identification of the journal - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher Education allocated to the activities of disseminating science.

Generation of the DOI (Digital Object Identifier) - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher
© 2006-2024 Journal hosting platform by Bentus
Scroll to top